Boehringer Ingelheim Venture Fund

Suggest edits

Follow us

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 20

Portfolio

Portfolio Tracker

Add info

Add round

29 Oct 2021

CAD $24,000,000

Venture capital (Series A)

Desjardins Venture Capital, Boehringer Ingelheim Venture Fund, Advisors.fund, +4

Optina raises $24 million to bolster AI-powered early Alzheimer detection device

BetaKit

23 Sep 2020

$29,000,000

Venture capital (Series A)

Dolby Family Ventures, Epidarex Capital, Sante Ventures, +3

Libra Therapeutics Raises $29M in Series A Funding

FinSMEs

11 Aug 2020

$11,200,000

Venture capital (Series A)

Kapor Capital, Initialized Capital, Playground Global, +1

Bodyport Raises $11.2M in Series A Funding

FinSMEs

16 Jun 2020

$4,500,000

Seed fund

Boehringer Ingelheim Venture Fund, JDRF T1D Fund, Advent France Biotechnology (AFB)

DiogenX Raises €4.5M in Seed Financing

FinSMEs

16 Jun 2020

€34,000,000

Venture capital (Series B)

Omega Funds, Boehringer Ingelheim Venture Fund, Fund+, +7

eTheRNA Raises €34M in Series B Financing

FinSMEs

10 Jan 2020

$22,000,000

Venture capital (Series C)

Boehringer Ingelheim Venture Fund, PPF Group

NBE-Therapeutics Completes USD22M Series C Financing Round

FinSMEs

08 Jan 2020

$30,000,000

Venture capital (Series B)

Boehringer Ingelheim Venture Fund

Eyevensys Raises $30M in Series B Financing

FinSMEs

03 Apr 2019

€21,000,000

Venture capital (Series A)

Omnes Capital, Boehringer Ingelheim Venture Fund, Pontifax, +2

Belgian biotherapeutics firm AgomAB inks Series A funding

PE HUB

04 Jan 2018

€15,200,000

Venture capital (Series A)

Boehringer Ingelheim Venture Fund, ParticipatieMaatschappij Vlaanderen, Merck Ventures BV, +2

| Belgian biotech company Rewind Therapeutics picks up Series A funding

PE HUB

11 Dec 2017

€27,000,000

Venture capital (Series A)

Novartis Venture Fund, LSP BioVentures, Boehringer Ingelheim Venture Fund, +2

11 Dec 2017

$59,600,000

Venture capital (Series C)

Sofinnova Partners, BioMedPartners, Forbion Capital Partners, +6

| Hookipa Biotech scores $59.6 mln Series C

PE HUB

04 Apr 2017

$12,000,000

Venture capital (Series A)

Mass Medical Angels, Chiesi Ventures, Boehringer Ingelheim Venture Fund, +2

Venture Capital Access Online | Venture Capital News

vcaonline

05 Jan 2017

€9,000,000

Venture capital (Series A)

Boehringer Ingelheim Venture Fund, Novo Seeds

HepaRegeniX Raises €9M in Series A Financing

FinSMEs

14 Dec 2016

€2,500,000

Venture capital

KfW Bankengruppe, Boehringer Ingelheim Venture Fund, Axxam

acousia Therapeutics Receives EUR 2 5 Million To Develop Innovative Therapy To Treat And Prevent Sensorineural Hearing Loss

biospace

27 Oct 2016

€10,000,000

Venture capital (Series C)

Mitsui & Co. Global Investment, Mitsubishi UFJ Capital, Boehringer Ingelheim Venture Fund, +4

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

businesswire

06 Sep 2016

€15,000,000

Venture capital (Series A)

High-Tech Gruenderfonds, Sunstone Capital, MP Healthcare Venture Management, +3

Rigontec Raises €15M in Third Closing of Series A Funding

FinSMEs

10 Apr 2016

€25,000,000

Venture capital (Series C)

Caixa Capital Risc, Idinvest Partners, Gilde Healthcare Partners, +4

STAT-Diagnostica secures EUR25m in Series C financing led by Gilde Healthcare\

Private Equity Wire

04 Apr 2016

$18,000,000

Venture capital (Series A)

MS Ventures, Boehringer Ingelheim Venture Fund, Pfizer, +4

Metabomed Raises $18M in Series A Funding

FinSMEs

28 Mar 2012

$31,475,320

Venture capital (Series B)

Mitsui & Co. Global Investment, Boehringer Ingelheim Venture Fund, Shire

Index

By TNW